Assistant/Associate Professor of Medicine; Hematology/Oncology
American Society of Clinical Oncology (ASCO) · New Brunswick, NJ
FULL-TIME
Posted Sep 21, 2026
190K–270K a year
Job Description
Position: Assistant/Associate Professor of Medicine (Hematology/Oncology)
Assistant/Associate Professor of Medicine (Hematology/Oncology)
Phase I Experimental Therapeutics Clinical Investigator
Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to join and help grow our Phase 1 Experimental Therapeutics Program
. The successful candidate will play a key role in the design, conduct, and expansion of early-phase clinical trials while increasing patient access to innovative cancer therapies at New Jersey's only NCI-Designated Comprehensive Cancer Center and across the RWJBarnabas Health system.
Candidates with an interest in Phase I trial development and translational research are encouraged to apply. Disease specialization is flexible and will be aligned with the successful candidate's clinical and research interests with opportunities to maintain and grow a disease-specific practice while participating in a robust early-phase therapeutics program.
Opportunity Highlights
• Conduct and develop early-phase clinical trials, including first-in-human, targeted therapy, immuno-oncology, and combination studies.
• Ensure protocol adherence and compliance with ICH-GCP, FDA regulations (21 CFR), IRB requirements, and institutional SOPs
.
• Author and review protocols, informed consent documents, abstracts, and manuscripts.
• Interpret and integrate
pharmacokinetic (PK), pharmacodynamic (PD), and correlative/biomarker data into clinical decision-making.
• Collaborate with sponsors, CROs, translational scientists, pharmacists, and research coordinators to advance study conduct and portfolio growth.
• Contribute to feasibility assessments, site selection, for new early-phase trials and expand access throughout the RWJBarnabas Health network.
• Mentor students, house staff, fellows, and junior faculty, and research staff.
• Startup support and research infrastructure will be provided to facilitate clinical trial development and academic growth.
The successful candidate will join the faculty of Rutgers Robert Wood Johnson Medical School on the Clinical Scholar track, with approximately 0.6 clinical FTE dedicated to supporting both academic and clinical priorities. Clinical practice will be located in the Jack & Sheryl Morris Cancer Center
, a state-of-the-art, freestanding cancer hospital designed to advance cancer research and patient care through multidisciplinary collaboration.
Candidate Qualifications
• MD or equivalent degree
• Completed or completing an accredited Hematology/Oncology fellowship program
• Board Certified or Board Eligible in Medical Oncology and/or Hematology
• Eligible for or currently holding a New Jersey medical license
• Demonstrated interest and experience in clinical research
• Experience in Phase I or early-phase clinical trials is preferred
Assistant/Associate Professor of Medicine (Hematology/Oncology)
Phase I Experimental Therapeutics Clinical Investigator
Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to join and help grow our Phase 1 Experimental Therapeutics Program
. The successful candidate will play a key role in the design, conduct, and expansion of early-phase clinical trials while increasing patient access to innovative cancer therapies at New Jersey's only NCI-Designated Comprehensive Cancer Center and across the RWJBarnabas Health system.
Candidates with an interest in Phase I trial development and translational research are encouraged to apply. Disease specialization is flexible and will be aligned with the successful candidate's clinical and research interests with opportunities to maintain and grow a disease-specific practice while participating in a robust early-phase therapeutics program.
Opportunity Highlights
• Conduct and develop early-phase clinical trials, including first-in-human, targeted therapy, immuno-oncology, and combination studies.
• Ensure protocol adherence and compliance with ICH-GCP, FDA regulations (21 CFR), IRB requirements, and institutional SOPs
.
• Author and review protocols, informed consent documents, abstracts, and manuscripts.
• Interpret and integrate
pharmacokinetic (PK), pharmacodynamic (PD), and correlative/biomarker data into clinical decision-making.
• Collaborate with sponsors, CROs, translational scientists, pharmacists, and research coordinators to advance study conduct and portfolio growth.
• Contribute to feasibility assessments, site selection, for new early-phase trials and expand access throughout the RWJBarnabas Health network.
• Mentor students, house staff, fellows, and junior faculty, and research staff.
• Startup support and research infrastructure will be provided to facilitate clinical trial development and academic growth.
The successful candidate will join the faculty of Rutgers Robert Wood Johnson Medical School on the Clinical Scholar track, with approximately 0.6 clinical FTE dedicated to supporting both academic and clinical priorities. Clinical practice will be located in the Jack & Sheryl Morris Cancer Center
, a state-of-the-art, freestanding cancer hospital designed to advance cancer research and patient care through multidisciplinary collaboration.
Candidate Qualifications
• MD or equivalent degree
• Completed or completing an accredited Hematology/Oncology fellowship program
• Board Certified or Board Eligible in Medical Oncology and/or Hematology
• Eligible for or currently holding a New Jersey medical license
• Demonstrated interest and experience in clinical research
• Experience in Phase I or early-phase clinical trials is preferred
Additional Details
- City
- New Brunswick
- State
- New Jersey
- Country
- US
Apply and matching require a free OVN account. Browse listings anytime without signing in.